Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,493-9,504 of 23,847
Drug study icon
CompletedEUCTR 2021-001172-41

Lumateperone for depression

This study is completed in Czechia, in Slovakia, in Hungary, .... It is testing lumateperone for depression.

In Czech Republic
DepressionOther
Countries
Czechia, Slovakia, Hungary, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression
Drug study icon
CompletedNCT01129882

An Rollover, Long-term Study of Aripiprazole Intramuscular Depot in people with Schizophrenia

This study is completed in the United States, in Australia, in Argentina, .... It is testing aripiprazole Intramuscular Depot for schizophrenia.

Multiple locations, including Bellevue
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, Argentina, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02186769

LY03004 Compared to Risperdal® Consta® for schizophrenia

This study is completed in the United States. It is testing LY03004 Compared to Risperdal® Consta® for schizophrenia.

Multiple locations, including Orange County
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.